Immunization with cardiac proteins, such as cTnI or cardiac myosin, induces the production of high titers of anti-cTnI-aAbs, which are associated with myocardial inflammation, fibrosis, impaired left ventricular ejection fraction, and ultimately heart failure [2,3,4]. This evidence concerns the gene TNNI3 and heart failure.